SBIR/STTR Just Got Its Biggest Overhaul in 30 Years: $30M Awards, Security Gates, and the End of 'Perpetual Phase I' Companies

For six months, the SBIR and STTR programs operated in legal limbo. Authorization expired on September 30, 2025, and while agencies continued making awards using previously appropriated funds, no new solicitations could reference program authority that technically no longer existed. Proposals sat in queues. Program managers hedged. Small businesses that depend on SBIR revenue watched their pipeline freeze.

On April 13, 2026, President Trump signed the Small Business Innovation and Economic Security Act (S.3971) into law. The bill doesn't just restart the clock — it rewrites the rules. SBIR/STTR is reauthorized through September 30, 2031, giving small businesses six years of program certainty for the first time since 2022. But the legislation also introduces structural reforms that will reshape who wins awards, how much they can win, and what the government expects in return.

The most consequential changes: Strategic Breakthrough Awards worth up to $30 million, expanded foreign ownership scrutiny that will disqualify some current recipients, application volume controls targeting firms that win repeatedly without commercializing, and a philosophical shift that repositions the entire program from standalone research grants to an integrated acquisition pathway.

The $30 Million Strategic Breakthrough Award

Traditional SBIR awards follow a well-understood progression. Phase I provides $50,000 to $275,000 (depending on agency) for six to twelve months of feasibility research. Phase II provides $600,000 to $2.8 million over two years for prototype development. Phase III — the commercialization phase — receives no dedicated SBIR funding; companies are expected to secure it from procurement budgets or private capital.

That Phase II-to-Phase III gap — the "Valley of Death" — has been the program's central failure mode for decades. Companies build promising prototypes on SBIR funding, then cannot bridge to production-scale manufacturing, regulatory approval, or acquisition integration. The technology dies not because it doesn't work but because $2 million is enough to prove feasibility and far too little to reach market.

S.3971 creates a new instrument: the Strategic Breakthrough Fund (SBF) award. An SBF award provides up to $30 million over four years — roughly ten times a traditional Phase II — specifically for technologies ready to cross the valley. These are not grants in the traditional sense. They are milestone-driven contracts that require demonstrated customer demand, validated technology readiness, and a credible pathway to either procurement integration or commercial revenue.

The implications for the defense industrial base are immediate. DARPA's SBIR topics opening May 6 — including the Smart Whole Blood Field Transfusion system (SWiFT) and the Broadening Availability of Regimens for K-9s (BARK) program — represent exactly the kind of medical countermeasure technology that SBF awards are designed to scale. A company that wins Phase I and Phase II on one of these topics now has a visible pathway to a $30 million follow-on, rather than the traditional dead end of "Phase III is someone else's problem."

The Security Gate

The second major change targets foreign influence. Previous SBIR/STTR rules included basic certification requirements about foreign government connections, but enforcement was inconsistent and definitions were narrow. S.3971 expands the framework significantly.

The legislation broadens definitions of Foreign Ownership, Control, or Influence (FOCI) and requires enhanced disclosure of:

• Funding sources from countries of concern (China, Russia, Iran, North Korea)
• Technology licensing agreements with foreign entities
• Joint ventures or partnership arrangements with foreign-connected parties
• Investment from foreign venture capital or sovereign wealth funds

Companies with any of these connections face heightened scrutiny during proposal evaluation. The bill doesn't automatically disqualify them — it creates a security review process that can result in denial on national security grounds, with mandatory notification to applicants citing the specific basis for rejection.

For the SBIR ecosystem, this means companies backed by Chinese or Russian-connected venture capital may need to restructure their cap tables before submitting proposals. Firms licensing technology from foreign universities or partnering with foreign companies on dual-use research will need to evaluate whether those relationships trigger FOCI disclosure requirements.

The practical effect will fall hardest on deep-tech startups — precisely the firms SBIR was designed to support. Many early-stage companies in AI, quantum computing, advanced materials, and biotechnology have accepted investment from globally diversified venture funds that include limited partners from countries of concern. Whether a minority LP stake in a multi-billion-dollar fund constitutes "foreign ownership" sufficient to trigger disclosure is the kind of interpretive question that will be litigated through program implementation.

The End of Perpetual Phase I Companies

Congress included a provision that few media reports have highlighted but that will reshape the applicant pool: agencies must now set annual limits on applications to "ensure fair access for truly small firms."

This targets a known pathology. A subset of SBIR recipients has built business models around winning Phase I awards in volume — submitting dozens of proposals per year across multiple agencies, winning enough to sustain payroll, but rarely advancing technologies to commercialization. These firms consume review bandwidth, crowd out first-time applicants, and generate low return on taxpayer investment.

The legislation doesn't specify hard caps. It empowers agencies to set "flexible limits tailored to year, topic, or portfolio needs" — meaning each agency can calibrate based on its applicant pool. But the direction is clear: firms that repeatedly win Phase I without demonstrating Phase II progression or commercial outcomes will face submission restrictions.

Combined with enhanced reporting requirements — agencies must now track commercial outcomes, follow-on contracts, and economic impact at the firm level — this creates accountability that the program has historically lacked. The data collection infrastructure mandated by S.3971 will, for the first time, generate a comprehensive picture of which firms are converting SBIR investment into actual products and which are running sophisticated grant-writing operations.

What Changed for Each Phase

Phase I. Technical and Business Assistance (TABA) funding is codified at $6,500 per project, with expanded allowable uses including cybersecurity planning and market analysis. The practical impact is modest — $6,500 won't fund serious consulting — but it signals that agencies expect Phase I proposals to include commercialization thinking from day one.

Phase II. TABA funding jumps to $50,000 per project, a meaningful amount for hiring a commercialization consultant, filing provisional patents, or conducting market validation research. Direct-to-Phase II authority, previously limited to SBIR, now extends to the STTR program, allowing DOE and NASA (newly added as eligible agencies) to fund companies that have already demonstrated feasibility through non-SBIR mechanisms.

Phase III. The legislation mandates contracting officer training on Phase III awards, standardized model contracts, improved acquisition workforce awareness, and consistent tracking of Phase III transitions. The intent is to close the cultural gap where contracting officers in operational commands don't know SBIR exists and therefore never pull Phase II technologies into procurement.

Carryover Funding and the Lapse Recovery

One provision addresses the damage from the six-month authorization lapse. S.3971 allows agencies to carry over unused FY2026 SBIR/STTR funds — money that was appropriated but couldn't be fully allocated during the lapse period — into subsequent fiscal years. This means the total available award funding for FY2026-2027 may exceed what agencies would normally allocate, as backed-up pipeline proposals get funded alongside new solicitations.

For applicants, this creates a temporary surge in available funding. Agencies with large backlogs — particularly DOD, which publishes SBIR topics on a quarterly cycle — may issue larger-than-normal award cohorts in the next two to three solicitation windows as they clear the pipeline.

Positioning for the New Landscape

The reauthorization rewards companies that can demonstrate three things the old SBIR rarely demanded: a clear customer, a credible transition pathway, and clean foreign-influence disclosures.

Review your cap table. If your investors include funds with LP exposure to countries of concern, understand the disclosure requirements before your next submission. Restructuring takes time; starting after a proposal is rejected on security grounds means losing a cycle.

Build transition evidence into Phase I proposals. With agencies now tracking commercialization outcomes at the firm level, proposals that articulate specific acquisition pathways or commercial customers will score better than those treating Phase I as pure research.

Target SBF-eligible topics. Not every SBIR topic will have a Strategic Breakthrough pathway, but agencies will signal which technology areas are candidates. Watch for BAA language referencing "transition funding" or "follow-on scaling support" — these are the topics where $30 million awards may emerge.

Track your submission volume. If you're submitting more than ten proposals per year across agencies, the new application limits may constrain your strategy. Consider concentrating effort on fewer, stronger proposals with clear Phase II and Phase III narratives rather than maximizing Phase I volume.

The SBIR/STTR reauthorization represents the most significant structural reform since the program's 1982 creation. For companies ready to demonstrate that their technology can cross from prototype to product, the funding ceiling just rose by an order of magnitude. For companies that have been cycling through Phase I awards without delivering results, the runway just got considerably shorter.

Granted tracks every open SBIR and STTR solicitation across all federal agencies, maps them to your organization's capabilities, and helps you identify which topics align with the new Strategic Breakthrough pathway — so you can focus proposal effort where the largest awards are heading.